Study: Naltrexone Use Prevents Relapse of Opioid Dependency

Written by Abby Callard | November 11, 2011 | Print  |
Using a once-monthly extended-release naltrexone intramuscular injection is an effective way to prevent opioid dependency relapse after detoxification, according to findings presented at the Annual U.S. Psychiatric and Mental Health Congress and a Medscape Medical News report. The year-long study was an extension of the original study that resulted in the drug's approval in Oct. 2010. Researchers looked at 67 previously treated patients and 47 patients who switched from placebo therapy. At the end of the trail, slightly more than half the patients were completely abstinent from opioid use.

Related Articles on Opioids:
7 Trends Affecting the Future of Pain Management in Surgery Centers
American Pain Society Supports CDC's Attention to Prescription Drug Misuse
Nano-formulated NSAIDs Provide Relief at Lower Doses

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months